STOCK TITAN

TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TransMedics Group, a leader in organ transplant technology, will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 8:00 a.m. ET. The conference will be held at the InterContinental Boston Hotel. The management team aims to discuss advancements in portable extracorporeal warm perfusion and organ assessment technologies, which enhance organ viability and increase transplant opportunities for patients with end-stage organ failure. A live webcast will be available on their website.

Positive
  • None.
Negative
  • None.

ANDOVER, Mass., July 26, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming Canaccord Genuity 42nd Annual Growth Conference at the InterContinental Boston Hotel. Management is scheduled to present on Wednesday, August 10, 2022, at 8:00 a.m. Eastern Standard Time.

Event: Canaccord Genuity 42nd Annual Growth Conference
Date: Wednesday, August 10, 2022
Time: 8:00 a.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
631-807-1986
Investors@transmedics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference-301593592.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics present at the Canaccord Genuity 42nd Annual Growth Conference?

TransMedics will present on August 10, 2022, at 8:00 a.m. ET.

Where is the Canaccord Genuity 42nd Annual Growth Conference being held?

The conference is being held at the InterContinental Boston Hotel.

How can I access the TransMedics presentation?

The presentation can be accessed via a live and archived webcast on the Investors section of the TransMedics website.

What is TransMedics Group known for?

TransMedics is known for its technologies in portable extracorporeal warm perfusion and organ assessment for transplantation.

What are the benefits of TransMedics' technology?

Their technology preserves organ quality and assesses organ viability, potentially increasing the availability of donor organs for transplantation.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

2.03B
32.48M
3.18%
112.86%
26.74%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ANDOVER